Leptin and obesity in ovarian dysfunction in menopause

Nutrition and Diet in Menopause

Volumn , Issue , 2013, Pages 255-270

  Diel, Patrick Rene ^a   Weigt, Carmen ^a  

^a GERMAN SPORT UNIVERSITY COLOGNE   (Germany)

Author keywords

Energy homeostasis; Estrogen receptor alpha; Estrogen receptor beta; Estrogens; Fat metabolism; Leptin; Menopause; Obesity

Indexed keywords

EID: 84885586766     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-62703-373-2_19     Document Type: Chapter

References (77)

1. Chan RS, Woo J. Prevention of overweight and obesity: how effective is the current public health approach. Int J Environ Res Public Health. 2010;7:765-83.
2. Newbold RR, Padilla-Banks E, Jefferson WN. Environmental estrogens and obesity. Mol Cell Endocrinol. 2009;304:84-9.
3. Caballero B. The global epidemic of obesity: an overview. Epidemiol Rev. 2007;29:1-5.
4. Low S, Chin MC, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singapore. 2009;38:57-9.
5. Comuzzie AG, Williams JT, Martin LJ, Blangero J. Searching for genes underlying normal variation in human adiposity. J Mol Med. 2001;79:57-70.
6. Goulart AC, Zee RY, Rexrode KM. Estrogen receptor 1 gene polymorphisms and decreased risk of obesity in women. Metabolism. 2009;58:759-64.
7. Ley CJ, Lees B, Stevenson JC. Sex- and menopause-associated changes in body-fat distribution. Am J Clin Nutr. 1992;55:950-4.
8. Rolland YM, Perry 3rd HM, Patrick P, Banks WA, Morley JE. Loss of appendicular muscle mass and loss of muscle strength in young postmenopausal women. J Gerontol A Biol Sci Med Sci. 2007;62:330-5.
9. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab. 2005;90:3847-53.
10. Hertrampf T, Degen GH, Kaid AA, et al. Combined effects of physical activity, dietary iso flavones and 17betaestradiol on movement drive, body weight and bone mineral density in ovariectomized female rats. Planta Med. 2006;72:484-7.
11. Hertrampf T, Seibel J, Laudenbach U, Fritzemeier KH, Diel P. Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats. Br J Pharmacol. 2008;153:1432-7. Fig. 19.9 Effects of exercise on visceral fat content and insulin sensitivity in already established obesity. Female rats (SHAM and OVX) were kept for 8 month on a high fat diet. After developing obesity, the animals were classified into sedentary (no ex) and exercise training (ex) groups ( n = 5). A subset of OVX animals were substituted with E2 for 6 weeks. After the intervention period the exercise training of obese animals resulted in a signi ficant decrease of visceral body fat ( a ) and an increase of insulin sensitivity ( b ). SHAM = SHAM-operated, OVX = ovariectomized, E2 = 17 b -estradiol, T0 = before treatment period, T1 = after treatment period. Data shown are means ± SEM. Mean values were signi ficantly different for the following comparisons: ( a ) asterisk vs. OVX no ex, ( b ) asterisk vs. T1OVX ex at the same time point ( p £ 0.05), modi fied from Zoth et al. [ 40 ]
12. Ropero AB, Alonso-Magdalena P, Quesada I, Nadal A. The role of estrogen receptors in the control of energy and glucose homeostasis. Steroids. 2008;73:874-9.
13. Miranda PJ, DeFronzo RA, Califf RM, Guyton JR. Metabolic syndrome: de finition, pathophysiology, and mechanisms. Am Heart J. 2005;149:33-45.
14. Eckel LA. The ovarian hormone estradiol plays a crucial role in the control of food intake in females. Physiol Behav. 2011;104:517-24.
15. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87:905-31.
16. Kuiper GG, Carlsson B, Grandien K, et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 1997;138:863-70.
17. Diel P. Tissue-specific estrogenic response and molecular mechanisms. Toxicol Lett. 2002;127:217-24.
18. Ohmichi M, Tasaka K, Kurachi H, Murata Y. Molecular mechanism of action of selective estrogen receptor modulator in target tissues. Endocr J. 2005;52:161-7.
19. Kuiper GG, Lemmen JG, Carlsson B, et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology. 1998;139:4252-63.
20. Horwitz KB, Koseki Y, McGuire WL. Estrogen control of progesterone receptor in human breast cancer: role of estradiol and antiestrogen. Endocrinology. 1978;103:1742-51.
21. Korach KS, Emmen JM, Walker VR, et al. Update on animal models developed for analyses of estrogen receptor biological activity. J Steroid Biochem Mol Biol. 2003;86:387-91.
22. Gustafsson JA. What pharmacologists can learn from recent advances in estrogen signalling. Trends Pharmacol Sci. 2003;24:479-85.
23. Carpenter KD, Korach KS. Potential biological functions emerging from the different estrogen receptors. Ann N Y Acad Sci. 2006;1092:361-73.
24. Koehler KF, Helguero LA, Haldosen LA, Warner M, Gustafsson JA. Re flections on the discovery and significance of estrogen receptor beta. Endocr Rev. 2005;26:465-78.
25. Henderson BE, Ross RK, Paganini-Hill A, Mack TM. Estrogen use and cardiovascular disease. Am J Obstet Gynecol. 1986;154:1181-6.
26. Turner CH, Sato M, Bryant HU. Raloxifene preserves bone strength and bone mass in ovariectomized rats. Endocrinology. 1994;135:2001-5.
27. Fillit H, Weinreb H, Cholst I, et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type. Psychoneuroendocrinology. 1986;11:337-45.
28. Colditz GA. Epidemiology of breast cancer. Findings from the nurses' health study. Cancer. 1993;71:1480-9.
29. Ogawa S, Chan J, Gustafsson JA, Korach KS, Pfaff DW. Estrogen increases locomotor activity in mice through estrogen receptor alpha: specificity for the type of activity. Endocrinology. 2003;144:230-9.
30. Hertrampf T, Gruca MJ, Seibel J, Laudenbach U, Fritzemeier KH, Diel P. The bone-protective effect of the phytoestrogen genistein is mediated via ER alpha-dependent mechanisms and strongly enhanced by physical activity. Bone. 2007;40:1529-35.
31. Hillisch A, Peters O, Kosemund D, et al. Dissecting physiological roles of estrogen receptor alpha and beta with potent selective ligands from structure-based design. Mol Endocrinol. 2004;18:1599-609.
32. Garey J, Morgan MA, Frohlich J, McEwen BS, Pfaff DW. Effects of the phytoestrogen coumestrol on locomotor and fear-related behaviors in female mice. Horm Behav. 2001;40:65-76.
33. Patisaul HB, Melby M, Whitten PL, Young LJ. Genistein affects ER beta- but not ER alpha-dependent gene expression in the hypothalamus. Endocrinology. 2002;143:2189-97.
34. Walf AA, Frye CA. ERbeta-selective estrogen receptor modulators produce antianxiety behavior when administered systemically to ovariectomized rats. Neuropsychopharmacology. 2005;30:1598-609.
35. van Beek AP, de Ruijter-Heijstek FC, Erkelens DW, de Bruin TW. Menopause is associated with reduced protection from postprandial lipemia. Arterioscler Thromb Vasc Biol. 1999;19:2737-41.
36. Weigt C, Hertrampf T, Zoth N, Fritzemeier KH, Diel P. Impact of estradiol, ER subtype specific agonists and genistein on energy homeostasis in a rat model of nutrition induced obesity. Mol Cell Endocrinol. 2012;351:227-38.
37. Dubey RK, Imthurn B, Barton M, Jackson EK. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen. Cardiovasc Res. 2005;66:295-306.
38. Matthews J, Gustafsson JA. Estrogen signaling: a subtle balance between ER alpha and ER beta. Mol Interv. 2003;3:281-92.
39. Horowitz JF, Klein S. Whole body and abdominal lipolytic sensitivity to epinephrine is suppressed in upper body obese women. Am J Physiol Endocrinol Metab. 2000;278:E1144-52.
40. Zoth N, Weigt C, Zengin S, et al. Metabolic effects of estrogen substitution in combination with targeted exercise training on the therapy of obesity in ovariectomized Wistar rats. J Steroid Biochem Mol Biol. 2012;130:64-72.
41. D'Eon TM, Souza SC, Aronovitz M, Obin MS, Fried SK, Greenberg AS. Estrogen regulation of adiposity and fuel partitioning. Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J Biol Chem. 2005;280:35983-91.
42. Cooke PS, Heine PA, Taylor JA, Lubahn DB. The role of estrogen and estrogen receptor-alpha in male adipose tissue. Mol Cell Endocrinol. 2001;178:147-54.
43. Foryst-Ludwig A, Clemenz M, Hohmann S, et al. Metabolic actions of estrogen receptor beta (ERbeta) are mediated by a negative cross-talk with PPARgamma. PLoS Genet. 2008;4:e1000108.
44. Velders M, Schleipen B, Fritzemeier KH, Zierau O, Diel P. Selective estrogen receptor-beta activation stimulates skeletal muscle growth and regeneration. FASEB J. 2012;26(5):1909-20. doi: 10.1096/fj.11-194779.
45. Hausberger FX. Behavior of transplanted adipose tissue of hereditarily obese mice. Anat Rec. 1959;135:109-13.
46. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature. 1994;372:425-32.
47. Margetic S, Gazzola C, Pegg GG, Hill RA. Leptin: a review of its peripheral actions and interactions. Int J Obes Relat Metab Disord. 2002;26:1407-33.
48. Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature. 2006;444:847-53.
49. Schwartz MW. Central nervous system regulation of food intake. Obesity (Silver Spring). 2006;14 Suppl 1 Suppl. 1:1S-8.
50. Schwartz MW. Brain pathways controlling food intake and body weight. Exp Biol Med (Maywood). 2001;226:978-81.
51. Taleb S, Herbin O, Ait-Oufella H, et al. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27:2691-8.
52. Anifandis G, Koutselini E, Louridas K, et al. Estradiol and leptin as conditional prognostic IVF markers. Reproduction. 2005;129:531-4.
53. Cervero A, Dominguez F, Horcajadas JA, Quinonero A, Pellicer A, Simon C. The role of the leptin in reproduction. Curr Opin Obstet Gynecol. 2006;18:297-303.
54. Ducy P, Amling M, Takeda S, et al. Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell. 2000;100:197-207.
55. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, in flammation, and hematopoiesis. J Leukoc Biol. 2000;68:437-46.
56. Kamohara S, Burcelin R, Halaas JL, Friedman JM, Charron MJ. Acute stimulation of glucose metabolism in mice by leptin treatment. Nature. 1997;389:374-7.
57. Minokoshi Y, Kim YB, Peroni OD, et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature. 2002;415:339-43.
58. Donato Jr J, Cravo RM, Frazao R, Elias CF. Hypothalamic sites of leptin action linking metabolism and reproduction. Neuroendocrinology. 2011;93:9-18.
59. Wabitsch M, Jensen PB, Blum WF, et al. Insulin and cortisol promote leptin production in cultured human fat cells. Diabetes. 1996;45:1435-8.
60. Gao Q, Horvath TL. Cross-talk between estrogen and leptin signaling in the hypothalamus. Am J Physiol Endocrinol Metab. 2008;294:E817-26.
61. Cento RM, Proto C, Spada RS, et al. Leptin levels in menopause: effect of estrogen replacement therapy. Horm Res. 1999;52:269-73.
62. Zoth N, Weigt C, Laudenbach-Leschowski U, Diel P. Physical activity and estrogen treatment reduce visceral body fat and serum levels of leptin in an additive manner in a diet induced animal model of obesity. J Steroid Biochem Mol Biol. 2010;122:100-5.
63. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med. 1996;334:292-5.
64. Vila R, Adan C, Rafecas I, Fernandez-Lopez JA, Remesar X, Alemany M. Plasma leptin turnover rates in lean and obese Zucker rats. Endocrinology. 1998;139:4466-9.
65. Dardeno TA, Chou SH, Moon HS, Chamberland JP, Fiorenza CG, Mantzoros CS. Leptin in human physiology and therapeutics. Front Neuroendocrinol. 2010;31:377-93.
66. Stephenson GD, Rose DP. Breast cancer and obesity: an update. Nutr Cancer. 2003;45:1-16.
67. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11:327-32.
68. Garofalo C, Surmacz E. Leptin and cancer. J Cell Physiol. 2006;207:12-22.
69. Bryzgalova G, Lundholm L, Portwood N, et al. Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am J Physiol Endocrinol Metab. 2008;295:E904-12.
70. Jones ME, Thorburn AW, Britt KL, et al. Aromatase-de ficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci U S A. 2000;97:12735-40.
71. Samaras K, Hayward CS, Sullivan D, Kelly RP, Campbell LV. Effects of postmenopausal hormone replacement therapy on central abdominal fat, glycemic control, lipid metabolism, and vascular factors in type 2 diabetes: a prospective study. Diabetes Care. 1999;22:1401-7.
72. Santen RJ, Allred DC, Ardoin SP, et al. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J Clin Endocrinol Metab. 2010;95:s1-66.
73. Beral V. Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 2003;362:419-27.
74. Naaz A, Yellayi S, Zakroczymski MA, et al. The soy iso flavone genistein decreases adipose deposition in mice. Endocrinology. 2003;144:3315-20.
75. Penza M, Montani C, Romani A, et al. Genistein affects adipose tissue deposition in a dose-dependent and genderspecific manner. Endocrinology. 2006;147:5740-51.
76. Latour MG, Shinoda M, Lavoie JM. Metabolic effects of physical training in ovariectomized and hyperestrogenic rats. J Appl Physiol. 2001;90:235-41.
77. Green JS, Stanforth PR, Rankinen T, et al. The effects of exercise training on abdominal visceral fat, body composition, and indicators of the metabolic syndrome in postmenopausal women with and without estrogen replacement therapy: the HERITAGE family study. Metabolism. 2004;53:1192-6.